The Food and Drug Administration has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.

FDA denies Unicycive's NDA for Oxylanthanum Carbonate due to vendor issues; company eyes quick resolution with alternate manufacturer in place.

FDA approves new blood test used to detect early Alzheimer's disease Trump administration reacts to Iran's major nuclear decision My wife and I have $7,000 a month in pensions and Social Security ...

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease ...

When Joe DeMayo’s donated kidney started to fail earlier than expected, he didn’t know that the drug he was taking could’ve left him vulnerable — and that one of the most formidable drug ...

FDA Approves PrEP Drug Requiring Only Two Injections Per Year Studies show lenacapavir, or Yeztugo, is more effective at preventing HIV transmission than oral PrEP.

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The twice-yearly formulation has the brand name Yeztugo.

On June 18, the U.S. Food and Drug Administration (FDA) approved the first medicine to prevent HIV that only has to be taken twice a year. People who are at high risk for HIV can now take the ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s spread among people given an injection twice a year in clinical ...

FDA Approves “Breakthrough” HIV Drug One problem: The Trump administration’s defunding of the fight against AIDS.